Thrombectomy for Treatment of Acute Stroke in the COVID-19 Pandemic | Zendy

Panagiotis Papanagiotou | Zendy; G. Parrilla | Zendy; L. Creed Pettigrew | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Thrombectomy for Treatment of Acute Stroke in the COVID-19 Pandemic

Author(s) -

Panagiotis Papanagiotou,

G. Parrilla,

L. Creed Pettigrew

Publication year - 2020

Publication title -

cerebrovascular diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.221

H-Index - 104

eISSN - 1421-9786

pISSN - 1015-9770

DOI - 10.1159/000511729

Subject(s) - medicine , covid-19 , stroke (engine) , pandemic , acute stroke , intensive care medicine , disease , virology , infectious disease (medical specialty) , tissue plasminogen activator , outbreak , engineering , mechanical engineering

This commentary will focus on the role of thrombectomy for the treatment of embolic stroke during the 2019 novel coronavirus disease (COVID-19). We will begin with review of recently promulgated guidelines for use of thrombectomy in COVID-19-associated stroke. We will then survey the reported experience of thrombectomy applied to treatment of large-vessel occlusion (LVO) stroke in COVID-19. We will conclude by discussing unusual challenges confronted by neuro-interventionalists seeking to perform thrombectomy in COVID-19 patients with acute LVO stroke.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research